Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Conavi Medical ( (TSE:CNVI) ) has issued an update.
Conavi Medical Corp. has announced the pricing and terms of its public offering of common shares, aiming to raise between $15 million and $20 million. The proceeds will be used to advance the development and testing of its Novasight 3.0 technology, with plans to submit a 510(k) clearance application to the U.S. FDA in Q3 2025. This offering, conducted with Bloom Burton Securities Inc., will help strengthen Conavi’s position in the medical device industry by enhancing its product development capabilities.
More about Conavi Medical
Conavi Medical Corp. is a commercial stage medical device company that specializes in designing, manufacturing, and marketing imaging technologies for minimally invasive cardiovascular procedures.
YTD Price Performance: -20.0%
Average Trading Volume: 4,608
Technical Sentiment Signal: Strong Buy
Current Market Cap: $6.13M
Learn more about CNVI stock on TipRanks’ Stock Analysis page.